Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Osteoporosis 4Breast Neoplasms 2Vitamin D Deficiency 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Lymphoma, Non-Hodgkin 1Lymphoma 1Bone Diseases, Metabolic 1Adenomatous Polyps 1Adenoma 1

Interventions

Zoledronic Acid 3Denosumab 3Vitamin D 2Risedronic Acid 2Letrozole 2Toremifene 1Ibandronic Acid 1Geritol 1Calcium Carbonate 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Bone Diseases, Metabolic × Calcium Carbonate × Clear all
NCT00352846 2013-07-02

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
135 enrolled 4 charts
Lymphoid

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡